Search Results - Distler O.

Refine Results
CSV Export
  1. 1

    EULAR recommendations for the treatment of systemic sclerosis: 2023 update

    Article | by Del Galdo, F; Lescoat, A; Conaghan, PG; Bertoldo, E; Colic, J; Santiago, T; Suliman, YA; Matucci-Cerinic, M; Gabrielli, A; Distler, O; Hoffmann-Vold, AM; Castellví, I; Balbir-Gurman, A; Vonk, M; Ananyeva, L; Rednic, S; Tarasova, A; Ostojic, P; Boyadzhieva, V; El Aoufy, K; Farrington, S; Galetti, I; Denton, CP; Kowal-Bielecka, O; Mueller-Ladner, U; Allanore, Y | Published 2025 |
    Other Authors: “…Distler, O…”
  2. 2

    Brief Report: Smoking in Systemic Sclerosis: A Longitudinal European Scleroderma Trials and Research Group Study

    Article | by Jaeger VK; Valentini G; Hachulla E; Cozzi F; Distler O; Airó P; Czirják L; Allanore Y; Siegert E; Rosato E; Matucci-Cerinic M; Caimmi C; Henes J; Carreira PE; Smith V; Del Galdo F; Denton CP; Ullman S; De Langhe E; Riccieri V; Alegre-Sancho JJ; Rednic S; Müller-Ladner U; Walker UA; EUSTAR coauthors | Published 2018 |
    Other Authors: “…Distler O…”
  3. 3

    Oral glucocorticoids for skin fibrosis in early diffuse systemic sclerosis: a target trial emulation study from the European Scleroderma Trials and Research group database.

    Article | by Mongin D; Matucci-Cerinic M; Walker UA; Distler O; Becvar R; Siegert E; Ananyeva LP; Smith V; Alegre-Sancho JJ; Yavuz S; Limonta M; Riemekasten G; Rezus E; Vonk M; Truchetet ME; Del Galdo F; Courvoisier DS; Iudici M | Published 2025 |
    Other Authors: “…Distler O…”
  4. 4

    Late skin fibrosis in systemic sclerosis: a study from the EUSTAR cohort

    Article | by Hughes M; Huang S; Alegre-Sancho JJ; Carreira PE; Engelhart M; Hachulla E; Henes J; Kerzberg E; Pozzi MR; Riemekasten G; Smith V; Szücs G; Vanthuyne M; Zanatta E; Distler O; Gabrielli AG; Hoffmann-Vold AM; Steen VD; Khanna D | Published 2023 |
    Other Authors: “…Distler O…”
  5. 5

    Is there a role for TNF-alpha antagonists in the treatment of SSc? EUSTAR expert consensus development using the Delphi technique

    Article | by Distler JH; Jordan S; Airo P; Alegre-Sancho JJ; Allanore Y; Balbir Gurman A; Caporali R; Caramaschi P; Carreira PE; Chizzolini C; Cutolo M; Tuncay Duruöz M; Farge-Bancel D; Hesselstrand R; Iannone F; De Keyser F; Kucharz EJ; Launay D; García de la Peña Lefebvre P; Lukacova O; Marasini B; Martinovic D; Marques Neto JF; Radic M; Rednic S; Riemekasten G; Rovensky J; Seidel MF; Senel S; Smith V; Sunderkötter C; Ton E; van Laar JM; Matucci-Cerinic M; Müller Ladner U; Distler O | Published 2011 |
    Other Authors: “…Distler O…”
  6. 6

    Prevalence, Correlates and Outcomes of Gastric Antral Vascular Ectasia in Systemic Sclerosis: A EUSTAR Case-control Study

    Article | by Ghrénassia E; Avouac J; Khanna D; Derk CT; Distler O; Suliman YA; Airo P; Carreira PE; Foti R; Granel B; Berezne A; Cabane J; Ingegnoli F; Rosato E; Caramaschi P; Hesselstrand R; Walker UA; Alegre-Sancho JJ; Zarrouk V; Agard C; Riccieri V; Schiopu E; Gladue H; Steen VD; Allanore Y | Published 2014 |
    Other Authors: “…Distler O…”
  7. 7

    Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort

    Article | by Kuster S; Jordan S; Elhai M; Held U; Steigmiller K; Bruni C; Cacciapaglia F; Vettori S; Siegert E; Rednic S; Codullo V; Airo P; Braun-Moscovici Y; Hunzelmann N; Joao Salvador M; Riccieri V; Gheorghiu AM; Alegre Sancho JJ; Romanowska-Prochnicka K; Castellví I; Kötter I; Truchetet ME; López-Longo FJ; Novikov PI; Giollo A; Shirai Y; Belloli L; Zanatta E; Hachulla E; Smith V; Denton C; Ionescu RM; Schmeiser T; Distler JHW; Gabrielli A; Hoffmann-Vold AM; Kuwana M; Allanore Y; Distler O | Published 2022 |
    Other Authors: “…Distler O…”
  8. 8

    Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study

    Article | by Elhai M; Boubaya M; Distler O; Smith V; Matucci-Cerinic M; Alegre Sancho JJ; Truchetet ME; Braun-Moscovici Y; Iannone F; Novikov PI; Lescoat A; Siegert E; Castellví I; Airó P; Vettori S; De Langhe E; Hachulla E; Erler A; Ananieva L; Krusche M; López-Longo FJ; Distler JHW; Hunzelmann N; Hoffmann-Vold AM; Riccieri V; Hsu VM; Pozzi MR; Ancuta C; Rosato E; Mihai C; Kuwana M; Saketkoo LA; Chizzolini C; Hesselstrand R; Ullman S; Yavuz S; Rednic S; Caimmi C; Bloch-Queyrat C; Allanore Y; for EUSTAR network | Published 2019 |
    Other Authors: “…Distler O…”
  9. 9

    The incidence of interstitial lung disease in patients with systemic sclerosis: rate, risk factors and prognostic implications in a EUSTAR cohort analysis (CP 133)

    Article | by Petelytska, L; Tofani, L; Velauthapillai, A; Dobrota, R; Becker, MO; Mihai, C; Muraru, S; Elhai, M; Jordan, S; Hachulla, E; Müller-Ladner, U; Siegert, E; Allanore, Y; Riemekasten, G; Bergmann, C; Becvar, R; Solanki, K; Anic, B; Szabo, I; Stamenkovic, B; Distler, J; Carreira, PE; Cuomo, G; Castellví, I; Balbir-Gurman, A; Airo, P; Litinsky, I; Saketkoo, LA; Bertaccini, B; Vonk, M; de Vries-Bouwstra, J; Hoffmann-Vold, AM; Matucci-Cerinic, M; Distler, O; Bruni, C | Published 2026 |
    Other Authors: “…Distler, O…”
  10. 10

    A comparative analysis of risk stratification tools in SSc-associated pulmonary arterial hypertension: a EUSTAR analysis

    Article | by Bjorkekjaer, HJ; Bruni, C; Broch, K; Brunborg, C; Carreira, PE; Airò, P; Simeón-Aznar, CP; Truchetet, ME; Giollo, A; Balbir-Gurman, A; Martin, M; Denton, CP; Gabrielli, A; Del Galdo, F; Vonk, MC; Fretheim, H; Bitter, H; Midtvedt,O; Andreassen, A; Hoie, S; Tanaka, Y; Riemekasten, G; Mueller-Ladner, U; Matucci-Cerinic, M; Castellví, I; Siegert, E; Hachulla, E; Molberg,O; Distler, O; Hoffmann-Vold, AM; EUSTAR Collaborators | Published 2025 |
    Other Authors: “…Distler, O…”

Search Tools: